Showing results (571-580 of 3,273) with videos related to
Sort By:
Pageof 328
Peerj|August 14, 2023
Data-specific substitution models improve protein-based phylogeneticsJoão M Brazão, Peter G Foster, Cymon J CoxPain Management|August 12, 2021
Successful spinal cord stimulation for chronic pancreatitis and post-laminectomy painCody J Cox, Michael M Wilkinson, Michael A ErdekThe American Journal of Drug and Alcohol Abuse|June 7, 2021
Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narrativesDavid J Cox, Albert Garcia-Romeu, Matthew W JohnsonJournal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)|October 18, 2003
Work-parenting linkages among dual-earner couples at the transition to parenthoodCatherine L Costigan, Martha J Cox, Ana Mari CaucePain|October 29, 2003
Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sampleLachlan A McWilliams, Brian J Cox, Murray W EnnsInternational Journal of Pharmaceutics|December 31, 2003
Solid state study of hydrogen bonding in dichlorophen crystalsPhilip J Cox, Nicola M Foote, Stephen M MacManusPediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|June 9, 2019
Recurrent Placental Transcriptional Profile With a Different Histological and Clinical Presentation: A Case ReportKatherine Leavey, Brian J Cox, Yvonne Cargill, et al.International Journal of Pharmaceutics|September 30, 2000
Hydrogen bonding in salicylsalicylic acid (salsalate) crystalsP J Cox, G I Gilmour, S M MacManusThe Clinical Journal of Pain|January 12, 2001
Impact of adult attachment styles on pain and disability associated with arthritis in a nationally representative sampleL A McWilliams, B J Cox, M W EnnsHaemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2001
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia AC Leissinger, D Becton, C Cornell, et al.Pageof 328